Replies to post #64259 on Blue Diamond Ventures Inc (BLDV)

[JPS02]

CannaTech 2017 - Oh Cannada! The Art of Storytelling and Superior Cannabis Branding @Tweed

Published on Apr 19, 2017

Enjoy this KNOCKOUT presentation from Canopy Growth CEO, Bruce Linton, as he speaks to the fine art of cannabis branding, as told through the lens of Tweed brand development. And enjoy a insider's peek at Canada's unique and evolving regulatory environment. You won't want to miss this one.

I found this YouTube clip interesting in terms of the potential success and the dynamics that BLDV could possibly have with AMS in Canada. Notice in the YouTube clip above, at:

1. 8:46: How Bruce mentions there is a reason he is in Israel. Connect this with the number of times BLDV has visited Israel!

2. 10:27: How Bruce starts explaining the investment and regulatory application challenges. I think these challenges are what make BLDV's role key to AMS to help them obtain the financing and finish the last step of the licensing process. Notice how the $12 million that BLDV is helping AMS obtain approval for is within the range of $10-15 million that Bruce mentions.

3. 16:43: Bruce explains the potential opportunities and ease of distributing cannabis with the upcoming legalization in Canada.

Go BLDV!

[Walker]

Check This Out - Eltron MJ Connection - makes even more sense now that they allowed BLDV and Canna Clean to move into their headquarters.

Anyone selling now will be missing out on a once in a lifetime opportunity IMO!!!

https://www.imn.org/real-estate/conference/The-Institutional-Capital-Cannabis-Conference-IC%C2%B3/highlight/28854

Took Place March 28th and 29th - look who was there:

CEO,
ELTRON RESEARCH & DEVELOPMENT

MedMen, an industry leading cannabis management services company and investment firm, and IMN, a premier finance and investment conference organizer, are pleased to announce The Institutional Capital & Cannabis Conference (IC³).

The legal cannabis market is forecast to be the fastest growing industry in America. Annual sales are projected to hit an astounding $80 billion in the next decade. In 2016, the U.S. posted a record $7.1 billion in sales, up from $5.7 billion in 2015 and $4.6 billion the year before. This double digit growth rate is expected to continue in the foreseeable future as more states legalize medical and recreational marijuana.

California, the most populous state in the union and the world's sixth largest economy, just approved adult use, along with Massachusetts, Nevada and Maine. They joined Washington, Oregon, Colorado and Alaska among states where recreational use is now legal. Florida, North Dakota and Arkansas approved medical use, bringing the total number of states with some form of legal cannabis to 28. Montana, which already had legalized medical marijuana, voted to create a formal program.

In anticipation of further legalization, MedMen and IMN are excited to host the inaugural The Institutional Capital & Cannabis Conference (IC³), the only event of its kind focused on the legal cannabis business as an alternative asset class to achieve portfolio diversification. This event has been created specifically with the needs of the institutional and accredited investor in mind.

IC³ will take place March 28-29, 2017 in San Jose at the Hayes Mansion. The program will provide an in-depth look into the emerging cannabis industry and show attendees how to evaluate investment returns in legal cannabis versus alternative investments.